Issue Resolved: Incorrect cost basis being used in pricing for Select Preferred Brands

The issue communicated yesterday where preferred brands with non-preferred generics were pricing with NADAC generic cost basis instead of NADAC brand has been resolved. Preferred brands with non-preferred generics will reimburse NADAC brand cost basis when the submitted DAW code is equal to 1 or 8 (or 7 for NTI drugs).